Craig-Hallum Maintains Buy on GeneDx Hldgs, Raises Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Bill Bonello has maintained a Buy rating on GeneDx Holdings (NASDAQ:WGS) and raised the price target from $46 to $70.
October 24, 2024 | 5:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Craig-Hallum has increased the price target for GeneDx Holdings from $46 to $70, maintaining a Buy rating. This suggests a positive outlook for the stock.
The increase in price target from $46 to $70 by Craig-Hallum indicates a strong positive sentiment from the analyst, suggesting potential upside in the stock price. The maintained Buy rating further supports this positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100